Matches in Wikidata for { <http://www.wikidata.org/entity/Q65359313> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q65359313 description "clinical trial" @default.
- Q65359313 description "ensayu clínicu" @default.
- Q65359313 description "klinisch onderzoek" @default.
- Q65359313 description "клінічне випробування" @default.
- Q65359313 description "կլինիկական փորձարկում" @default.
- Q65359313 name "Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors" @default.
- Q65359313 name "Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors" @default.
- Q65359313 type Item @default.
- Q65359313 label "Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors" @default.
- Q65359313 label "Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors" @default.
- Q65359313 prefLabel "Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors" @default.
- Q65359313 prefLabel "Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors" @default.
- Q65359313 P1132 Q65359313-75E80A3F-028F-4EE1-A91D-6F9F46F272D7 @default.
- Q65359313 P1476 Q65359313-214CD99F-667C-49F1-8EB0-FFF71B683512 @default.
- Q65359313 P17 Q65359313-4AC433B3-E338-46ED-88B7-7CA03A98AC55 @default.
- Q65359313 P2899 Q65359313-5284F9BC-649C-4DD8-A315-4AF456A1B2A5 @default.
- Q65359313 P3098 Q65359313-930C1586-5B6D-43F8-A823-3FFDDF237891 @default.
- Q65359313 P31 Q65359313-73B47D5D-E88C-4225-BA7A-81E1C363036B @default.
- Q65359313 P4844 Q65359313-42146A6D-1D48-4D08-8886-059452C8ADB0 @default.
- Q65359313 P580 Q65359313-CCFB67FE-4BD0-43AB-9967-3C0AA1C32850 @default.
- Q65359313 P582 Q65359313-A8AD78E3-5035-473A-9B91-C2E6569FE20C @default.
- Q65359313 P6099 Q65359313-923CDF2B-F4AB-467E-8F6C-C2A330F9C85D @default.
- Q65359313 P6153 Q65359313-967D4CAF-2F44-442A-9EAC-78D7A5C57F34 @default.
- Q65359313 P8363 Q65359313-C2489448-6CBE-403C-B423-75233C3B602E @default.
- Q65359313 P1132 "+74" @default.
- Q65359313 P1476 "A Phase 1, Open-Label, Non-Randomized, Dose-Escalating Safety, Tolerability and Pharmacokinetic Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors" @default.
- Q65359313 P17 Q30 @default.
- Q65359313 P2899 "+18" @default.
- Q65359313 P3098 "NCT02134067" @default.
- Q65359313 P31 Q30612 @default.
- Q65359313 P4844 Q423762 @default.
- Q65359313 P580 "2014-08-01T00:00:00Z" @default.
- Q65359313 P582 "2018-11-01T00:00:00Z" @default.
- Q65359313 P6099 Q5452194 @default.
- Q65359313 P6153 Q1808012 @default.
- Q65359313 P8363 Q78089383 @default.